1. A randomised comparison of FLAG‐Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial. (6th April 2022) Authors: Russell, Nigel H.; Hills, Robert K.; Kjeldsen, Lars; Clark, Richard E.; Ali, Sahra; Cahalin, Paul; Thomas, Ian F.; Burnett, Alan K. Journal: British journal of haematology Issue: Volume 198:Number 3(2022) Page Start: 528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomised evaluation of low‐dose Ara‐C plus pegylated recombinant arginase BCT‐100 versus low dose Ara‐C in older unfit patients with acute myeloid leukaemia: Results from the LI‐1 trial. (22nd November 2022) Authors: Mussai, Francis; De Santo, Carmela; Cheng, Paul; Thomas, Ian F.; Ariti, Cono; Upton, Laura; Scarpa, Ugo; Stavrou, Victoria; Sydenham, Mia; Burnett, Alan K.; Knapper, Steven K.; Mehta, Priyanka; McMullin, Mary F.; Copland, Mhairi; Russell, Nigel H.; Dennis, Mike Journal: British journal of haematology Issue: Volume 200:Number 5(2023) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. (17th December 2018) Authors: Rule, Simon; Cook, Gordon; Russell, Nigel H.; Hunter, Ann; Robinson, Stephen; Morley, Nick; Sureda, Anna; Patrick, Pip; Clifton‐Hadley, Laura; Adedayo, Toyin; Kirkwood, Amy; Peggs, Karl S. Journal: British journal of haematology Issue: Volume 184:Number 6(2019) Page Start: 999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An immunophenotypic pre‐treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38low blasts. (14th April 2015) Authors: Khan, Naeem; Freeman, Sylvie D.; Virgo, Paul; Couzens, Steve; Richardson, Peter; Thomas, Ian; Grech, Angela; Vyas, Paresh; Grimwade, David; Russell, Nigel H.; Burnett, Alan K.; Hills, Robert K. Journal: British journal of haematology Issue: Volume 170:Number 1(2015:Jul.) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study. (2nd February 2021) Authors: Kayser, Sabine; Hills, Robert K.; Langova, Ralitsa; Kramer, Michael; Guijarro, Francesca; Sustkova, Zuzana; Estey, Elihu H.; Shaw, Carole M.; Ráčil, Zdeněk; Mayer, Jiri; Zak, Pavel; Baer, Maria R.; Brunner, Andrew M.; Szotkowski, Tomas; Cetkovsky, Petr; Grimwade, David; Walter, Roland B.; Burnett... Journal: British journal of haematology Issue: Volume 192:Number 5(2021) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses. Issue 8 (10th March 2021) Authors: Burnett, Alan K.; Russell, Nigel H.; Hills, Robert K.; Knapper, Stephen; Freeman, Sylvie; Huntly, Brian; Clark, Richard E.; Thomas, Ian F.; Kjeldsen, Lars; McMullin, Mary Frances; Drummond, Mark; Kell, Jonathan; Spearing, Ruth Journal: Journal of clinical oncology Issue: Volume 39:Issue 8(2021) Page Start: 890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia. (5th March 2019) Authors: Bailey, Graham D.; Qutob, Haitham M. H.; Akhtar, Asma; Russell, Nigel H.; Seedhouse, Claire H. Journal: British journal of haematology Issue: Volume 186:Number 2(2019) Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gemtuzumab ozogamicin in (KMT2A)‐rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials. (19th November 2021) Authors: Dillon, Richard; Hills, Robert K.; Burnett, Alan K.; Russell, Nigel H. Journal: British journal of haematology Issue: Volume 196:Number 5(2022) Page Start: e50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults. (5th December 2018) Authors: Freeman, Sylvie D.; Hills, Robert K.; Russell, Nigel H.; Cloos, Jacqueline; Kelder, Angèle; Ossenkoppele, Gert J.; Schuurhuis, Gerrit J. Journal: British journal of haematology Issue: Volume 186:Number 1(2019) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial. (12th July 2020) Authors: Jackson, Graham H.; Pawlyn, Charlotte; Cairns, David A.; Striha, Alina; Collett, Corinne; Waterhouse, Anna; Jones, John R.; Wilson, Jamie; Taylor, Craig; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D.; Karunanithi, Kamaraj; Lindsay, Jindriska; Jenner, Matthew W.; Cook, Gordon; Russell, Nigel H.... Journal: British journal of haematology Issue: Volume 192:Number 5(2021) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗